Literature DB >> 14743347

Characterisation of chicken TES and its role in cell spreading and motility.

Elen Griffith1, Amanda S Coutts, Donald M Black.   

Abstract

Previously we identified TES as a candidate tumour suppressor gene that is located at human chromosome 7q31.1. More recently, we and others have shown TES to encode a novel LIM domain protein that localises to focal adhesions. Here, we present the cloning and functional analysis of the chicken orthologue of TES, cTES. The TES proteins are highly conserved between chicken and human, showing 89% identity at the amino acid level. We show that the cTES protein localised at focal adhesions, actin stress fibres, and sites of cell-cell contact, and GST-cTES can pull-down zyxin and actin. To investigate a functional role for cTES, we looked at the effect of its overexpression on cell spreading and cell motility. Cells overexpressing cTES showed increased cell spreading on fibronectin, and decreased cell motility, compared to RCAS vector transfected control cells. The data from our studies with cTES support our previous findings with human TES and further implicate TES as a member of a complex of proteins that function together to regulate cell adhesion and additionally demonstrate a role for TES in cell motility. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743347     DOI: 10.1002/cm.10162

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  14 in total

1.  TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer.

Authors:  Yang Yongbin; Li Jinghua; Zhao Zhanxue; Zang Aimin; Jia Youchao; Shang Yanhong; Jiao Manjing
Journal:  Tumour Biol       Date:  2014-08-15

2.  Knockout mice reveal a tumor suppressor function for Testin.

Authors:  Alessandra Drusco; Nicola Zanesi; Claudia Roldo; Francesco Trapasso; John L Farber; Louise Y Fong; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-20       Impact factor: 11.205

Review 3.  Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Authors:  Alessandra Drusco; Yuri Pekarsky; Stefan Costinean; Anna Antenucci; Laura Conti; Stefano Volinia; Rami I Aqeilan; Kay Huebner; Nicola Zanesi
Journal:  J Biomed Biotechnol       Date:  2010-12-29

4.  Strain matrix-dependently dissociates gut epithelial spreading and motility.

Authors:  Lakshmi S Chaturvedi; Samira A Saad; Neil Bakshi; Harold M Marsh; Marc D Basson
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

5.  Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.

Authors:  Robert J Weeks; Ursula R Kees; Sarah Song; Ian M Morison
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

6.  TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells.

Authors:  Robert J Weeks; Jackie L Ludgate; Gwenn LeMée; Ian M Morison
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  TES inhibits colorectal cancer progression through activation of p38.

Authors:  Huili Li; Kun Huang; Lu Gao; Lixia Wang; Yanfeng Niu; Hongli Liu; Zheng Wang; Lin Wang; Guobin Wang; Jiliang Wang
Journal:  Oncotarget       Date:  2016-07-19

8.  LIM domain protein TES changes its conformational states in different cellular compartments.

Authors:  Yingli Zhong; Jiaolian Zhu; Yan Wang; Jianlin Zhou; Kaiqun Ren; Xiaofeng Ding; Jian Zhang
Journal:  Mol Cell Biochem       Date:  2008-08-12       Impact factor: 3.842

9.  Delineating the Tes Interaction Site in Zyxin and Studying Cellular Effects of Its Disruption.

Authors:  Ermin Hadzic; Marie Catillon; Aliaksandr Halavatyi; Sandrine Medves; Marleen Van Troys; Michèle Moes; Michelle A Baird; Michael W Davidson; Elisabeth Schaffner-Reckinger; Christophe Ampe; Evelyne Friederich
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.

Authors:  Yu Bai; Quan-Geng Zhang; Xin-Hua Wang
Journal:  Eur J Med Res       Date:  2014-12-11       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.